Warning: The NCBI web site requires JavaScript to function. more...
The control of viral infection by tripartite motif proteins and cyclophilin A.
Towers GJ.
Retrovirology. 2007 Jun 12;4:40. Review.
Related citations
Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
Ylinen LM, Keckesova Z, Webb BL, Gifford RJ, Smith TP, Towers GJ.
J Virol. 2006 Aug;80(15):7332-8.
Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
Keckesova Z, Ylinen LM, Towers GJ.
J Virol. 2006 May;80(10):4683-90.
Evolution of a TRIM5-CypA splice isoform in old world monkeys.
Newman RM, Hall L, Kirmaier A, Pozzi LA, Pery E, Farzan M, O'Neil SP, Johnson W.
PLoS Pathog. 2008 Feb 29;4(2):e1000003.
Retroviral restriction factors TRIM5α: therapeutic strategy to inhibit HIV-1 replication.
Zhang J, Ge W, Zhan P, De Clercq E, Liu X.
Curr Med Chem. 2011;18(17):2649-54. Review.
Control of viral infectivity by tripartite motif proteins.
Hum Gene Ther. 2005 Oct;16(10):1125-32. Review.
Anti-retroviral activity of TRIM5 alpha.
Nakayama EE, Shioda T.
Rev Med Virol. 2010 Mar;20(2):77-92. Review.
Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
Stremlau M, Perron M, Welikala S, Sodroski J.
J Virol. 2005 Mar;79(5):3139-45.
The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.
Song B, Gold B, O'Huigin C, Javanbakht H, Li X, Stremlau M, Winkler C, Dean M, Sodroski J.
J Virol. 2005 May;79(10):6111-21.
Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses.
Schaller T, Ylinen LM, Webb BL, Singh S, Towers GJ.
J Virol. 2007 Sep;81(18):10055-63. Epub 2007 Jul 3.
TRIM5alpha.
Song B.
Curr Top Microbiol Immunol. 2009;339:47-66. Review.
TRIM5α and Species Tropism of HIV/SIV.
Front Microbiol. 2012;3:13. Epub 2012 Jan 24.
An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins.
Schaller T, Hué S, Towers GJ.
J Virol. 2007 Nov;81(21):11713-21. Epub 2007 Aug 29.
Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.
Yap MW, Dodding MP, Stoye JP.
J Virol. 2006 Apr;80(8):4061-7.
Cyclophilin, TRIM5, and innate immunity to HIV-1.
Sokolskaja E, Luban J.
Curr Opin Microbiol. 2006 Aug;9(4):404-8. Epub 2006 Jul 3. Review.
Independent evolution of an antiviral TRIMCyp in rhesus macaques.
Wilson SJ, Webb BL, Ylinen LM, Verschoor E, Heeney JL, Towers GJ.
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3557-62. Epub 2008 Feb 19.
Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
Li X, Li Y, Stremlau M, Yuan W, Song B, Perron M, Sodroski J.
J Virol. 2006 Jul;80(13):6198-206.
Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1.
Stremlau M, Song B, Javanbakht H, Perron M, Sodroski J.
Virology. 2006 Jul 20;351(1):112-20. Epub 2006 Apr 27.
Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
Langelier CR, Sandrin V, Eckert DM, Christensen DE, Chandrasekaran V, Alam SL, Aiken C, Olsen JC, Kar AK, Sodroski JG, Sundquist WI.
J Virol. 2008 Dec;82(23):11682-94. Epub 2008 Sep 17.
Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.
Berthoux L, Sebastian S, Sokolskaja E, Luban J.
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14849-53. Epub 2005 Oct 3.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on